Thermo Fisher Scientific (TMO) Deferred Taxes (2009 - 2026)

Thermo Fisher Scientific has disclosed Deferred Taxes across 18 years of filings, most recently posting -$258.0 million for Q1 2026.

• Quarterly Deferred Taxes rose 7.53% year-over-year to -$258.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$618.0 million (up 64.5% YoY) and the FY2025 annual result came in at -$639.0 million, up 47.15% from the prior year.
• Deferred Taxes eased to -$258.0 million in Q1 2026, from $89.0 million in the prior quarter.
• Over five years, Deferred Taxes peaked at $339.0 million in Q2 2022 and troughed at -$1.9 billion in Q4 2023.
• A 5-year average of -$141.8 million and a median of $89.0 million in 2025 frame the typical range for Deferred Taxes.
• Annual changes were most pronounced in 2022 — Deferred Taxes jumped 1512.5% — and 2023, when it sank 1551.88%.
• Tracing TMO's Deferred Taxes over 5 years: stood at $133.0 million in 2022, then plunged by 1551.88% to -$1.9 billion in 2023, then surged by 89.54% to -$202.0 million in 2024, then surged by 144.06% to $89.0 million in 2025, then slumped by 389.89% to -$258.0 million in 2026.
• Business Quant data shows TMO's Deferred Taxes at -$258.0 million in Q1 2026, $89.0 million in Q4 2025, and -$127.0 million in Q3 2025.